NEW YORK Suboxone is taken as either a tablet or a small film that is dissolved under the tongue. "I think that it works great for patients that were abusing pills by mouth or by inhaling them nasally. The medication kind of acts as a ... TheStreet.com, 2 days ago
1 images for "Suboxone Tablets"
Actavis plc's (ACT) shares gained 4.7% with the company posting strong fourth quarter results. Fourth quarter 2013 earnings came in at $3.17 per share, well above the Zacks Consensus Estimate of $3.06 per share and 99.4% above the year-ago earnings.Yahoo! Singapore, 1 week ago
Actavis Net Revenue Increases 59% to $2.779 Billion in Fourth Quarter 2013; Non-GAAP EPS Increases 99% to $3.17
DUBLIN, Feb. 20, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) today reported net revenue increased 59 percent to $2.779 billion for the fourth quarter ended December 31, 2013, compared to $1.75 billion in the fourth quarter 2012. On a non-GAAP ...TickerTech.com, 2 weeks ago Actavis, Inc. Earnings Whispers, 1 month ago Actavis to Exceed Estimates Earnings Whispers, 1 month ago Actavis Announces Preliminary Financial Performance for FY 2013 Barchart, 1 month ago
Specialty pharmaceutical company Actavis Plc. (ACT: Quote), which earlier this week agreed to acquire rival drug maker Forest Laboratories Inc. (FRX) for about $25 billion in cash and stock, Thursday reported a loss for the fourth quarter, compared ...RTTNews.com, 2 weeks ago Actavis Supplies Outlook for Continued Long-Term Growth 4 Traders, 3 weeks ago Actavis Provides Outlook for Continued Long-Term Growth Individual.com, 4 weeks ago Actavis Provides 2014 Guidance Earnings Whispers, 1 month ago
TARGETS EXCEEDED - ANOTHER STRONG YEAR Results at a glance (unaudited) Q4 £m % change actual exchange % change constant exchange FY £m % change actual exchange % change constant exchange ...4 Traders, 3 weeks ago Full Year Results 2013 TrustNet, 3 weeks ago Week Ahead: Lloyds Bank set to reveal another year of losses Proactive Investors.co.uk, 3 weeks ago
Reckitt Benckiser Group ( OTCPK:RBGPF ) Q4 2013 Earnings Call February 12, 2014 3:30 AM ET Rakesh Kapoor Right. Good morning, and welcome to RB's Full Year 2013 Results. I'm going to take very brief opening comments, and then I'm going to give ...Seeking Alpha, 3 weeks ago Reckitt Benckiser Group Management Discusses 2013 Results - Earnings Call Transcript Seeking Alpha, 3 weeks ago
Nothing makes analysts happier these days than a prospective spinoff. And with a new chairman stepping in to help conduct the ongoing strategic review of the struggling Reckitt Benckiser pharma unit, some say one could be on the way for the British ...FiercePharma, 3 weeks ago
Reckitt Benckiser (Xetra: A0M1W6 - news) exploring sale of drug addiction treatment as profits fall for first time The chief executive of consumer goods giant Reckitt Benckiser says all options are on the table regarding the future of its ...Yahoo! UK and Ireland, 3 weeks ago Reckitt Benckiser FY13 Profit Declines, Targets Upto 5% Revenue Growth In 2014 RTTNews.com, 3 weeks ago Reckitt's sales growth to slow as conditions become more challenging Yahoo! UK and Ireland, 3 weeks ago
(Updates with analyst comment in fourth paragraph.) Feb. 12 (Bloomberg) -- Reckitt Benckiser Group Plc, the maker of Nurofen painkillers and Dettol handwash, predicted slower sales growth this year amid more difficult conditions in some of the ...Washington Post, 3 weeks ago
iNVEZZ.com, Tuesday, February 11: Shares in Reckitt Benckiser Group (LON:RB) opened 0.50 percent lower this morning but quickly gained ground to be trading close to yesterday's closing level. The Anglo-Dutch consumer goods company is tomorrow due ...Invezz, 3 weeks ago Reckitt Benckiser share price rises on bullish FY statement Invezz, 3 weeks ago
on your WebpageAdd Widget >Get your members hooked!